Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies
GlyToucan Accession Number: G49888UY
Peak | Intensity |
---|---|
306.0 | 718.0 |
307.1 | 114.0 |
308.0 | 221.0 |
323.1 | 1919.0 |
325.2 | 630.0 |
341.1 | 763.0 |
341.5 | 643.0 |
353.1 | 631.0 |
369.1 | 603.0 |
383.0 | 1605.0 |
385.3 | 1033.0 |
449.1 | 312.0 |
466.8 | 901.0 |
467.1 | 277.0 |
468.2 | 927.0 |
485.1 | 496.0 |
486.1 | 404.0 |
515.2 | 1314.0 |
578.4 | 209.0 |
596.1 | 1226.0 |
596.6 | 1218.0 |
597.2 | 1306.0 |
608.1 | 1252.0 |
629.2 | 902.0 |
634.2 | 2866.0 |
635.4 | 601.0 |
647.4 | 323.0 |
648.3 | 1042.0 |
650.2 | 1941.0 |
650.5 | 1001.0 |
651.2 | 477.0 |
666.0 | 354.0 |
666.3 | 150.0 |
677.4 | 5717.0 |
677.7 | 2260.0 |
678.3 | 2169.0 |
679.2 | 743.0 |
694.2 | 938.0 |
705.3 | 1385.0 |
707.6 | 602.0 |
732.3 | 672.0 |
749.3 | 157.0 |
749.7 | 3525.0 |
758.3 | 8820.0 |
758.9 | 2917.0 |
759.2 | 3889.0 |
759.8 | 965.0 |
779.3 | 389.0 |
779.8 | 1161.0 |
780.1 | 1198.0 |
809.3 | 3226.0 |
810.5 | 1719.0 |
821.4 | 723.0 |
822.3 | 537.0 |
824.3 | 776.0 |
824.6 | 660.0 |
827.1 | 727.0 |
827.3 | 2259.0 |
828.1 | 656.0 |
830.4 | 992.0 |
830.8 | 954.0 |
833.0 | 413.0 |
839.8 | 1056.0 |
844.1 | 320.0 |
851.2 | 674.0 |
851.9 | 487.0 |
852.4 | 2078.0 |
860.3 | 1544.0 |
860.8 | 6678.0 |
861.3 | 1932.0 |
861.8 | 496.0 |
862.3 | 1305.0 |
869.3 | 216.0 |
880.2 | 377.0 |
881.8 | 197.0 |
882.2 | 887.0 |
890.9 | 1948.0 |
898.3 | 121.0 |
899.1 | 819.0 |
899.5 | 915.0 |
900.0 | 929.0 |
904.1 | 460.0 |
907.0 | 2498.0 |
911.2 | 2329.0 |
911.9 | 2738.0 |
912.4 | 1512.0 |
914.0 | 354.0 |
914.6 | 1482.0 |
920.7 | 470.0 |
920.9 | 513.0 |
924.7 | 1082.0 |
925.0 | 389.0 |
954.5 | 538.0 |
971.2 | 511.0 |
971.4 | 1157.0 |
972.3 | 694.0 |
1014.3 | 218.0 |
1032.5 | 996.0 |
1056.4 | 532.0 |
1152.2 | 728.0 |
1176.5 | 545.0 |
1193.4 | 264.0 |
1254.5 | 308.0 |
1477.7 | 513.0 |
1517.6 | 2222.0 |
1519.5 | 252.0 |
1561.5 | 500.0 |
1660.8 | 1696.0 |
1661.7 | 278.0 |